July 23, 2013
Ruling in favor of Finnegan client DuPont, the U.S. Court of Appeals for the Federal Circuit affirmed a district court’s judgment as a matter of law, finding that a patent application claim by Novozymes A/S lacks adequate written description. Finnegan represented DuPont in this matter.
Press Release
August 19, 2026
Press Release
August 18, 2026
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.